Articles
May 29, 2020
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Last related news
October 8, 2024
Kasznar Leonardos publishes an article in the renowned IP Watchdog
We are proud to announce that our partner, Viviane Trojan, alongside legal team members Jorge Enrique de Azevedo Tinoco and Felipe Zanini … Kasznar Leonardos publishes an article in the renowned IP Watchdog
July 18, 2024
Kasznar Leonardos provides an overview of Data Protection in Brazil’s Best Counsel 2024
We are pleased to announce that our partner Claudio Barbosa and attorney at law Larissa Ferreira Martins took part of the publication … Kasznar Leonardos provides an overview of Data Protection in Brazil’s Best Counsel 2024
July 2, 2024
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide! Our partners Priscila Kashiwabara … Life Sciences’ Brazil Global Guide 2024 is now available